Influx Healthtech IPO
Influx Healthtech is an NSE SME IPO listed on the NSE SME platform, priced at ₹91–₹96 per share. The stock debuted at ₹132.5, delivering a listing gain of 38.0%. The IPO had a lot size of ₹1200 shares and a minimum investment of ₹1,15,200.
Influx Healthtech Limited IPO
- IPO Dates
- Jun 18, 2025 – Jun 20, 2025
- Price band
- ₹91-96 per equity share
- Minimum Investment
- ₹1,15,200
- Issue size
- ₹58.56 Cr
- Lot size
- 1200
- Allotment Date
- Jun 23, 2025
- Listing
- Jun 25, 2025
- Listing At
- NSE SME
IPO timeline
-
Jun 18, 2025
Open Date
Completed
-
Jun 20, 2025
Close Date
Completed
-
Jun 23, 2025
Allotment Date
Completed
-
Jun 25, 2025
Listing Date
Completed
Influx Healthtech IPO Essentials
Influx Healthtech IPO Details
Influx Healthtech IPO is priced at ₹91-96 per share with a total issue size of 58.56 crore. The IPO has a lot size of 1200 shares and is listed on NSE SME.
- Issue price
- ₹91-96 per equity share
- Lot size
- 1200 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 61,00,800 shares(aggregating up to ₹58.56 Cr)
- Total issue size
- 61,00,800 shares
(aggregating up to ₹58.56 crore) - Fresh issue
- 50,00,400 shares
(aggregating up to ₹48 crore) - Offer for sale (OFS)
- 11,00,400 shares
(aggregating up to ₹10.56 crore) - Listing at
- NSE SME
- List price
- 132.5
- Listing date
- Registrar
- Maashitla Securities Private Limited
- Lead manager
-
Rarever Financial Advisors Pvt. Ltd
Market Lot Size
Investors can bid for a minimum of 1200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 1200 | ₹1,15,200 |
| Retail(max) | 1 | 1200 | ₹1,15,200 |
| NII (min) | 2 | 2,400 | ₹2,30,400 |
Influx Healthtech IPO Reservation
Influx Healthtech IPO reservation details show category-wise allocation of shares. Out of the total 32,64,000 shares, approximately 18.97% are reserved for QIB, 14.26% for NII, 33.28% for retail investors, 5.05% for market maker, and 28.43% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (28.43%) | |
| Market Maker Shares Offered | NA (5.05%) | |
| QIB Shares Offered | NA (18.97%) | |
| NII (HNI) Shares Offered | 4,65,600 (14.26%) | |
| Retail Shares Offered | 10,86,400 (33.28%) | |
| Total Shares Offered | 32,64,000 (100%) |
Influx Healthtech IPO Analytics
Influx Healthtech IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Influx Healthtech IPO Subscription Status
Influx Healthtech IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO subscription status indicates investor demand across categories.
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 11,59,200 / 8,70,000 | 20,29,200 | 40,58,400 |
|
Day 1
18-06-25 06:00 PM
|
(1.46 / 5.81) x | 8.46 x | 5.89 x |
|
Day 2
19-06-25 06:00 PM
|
(1.69 / 32.28) x | 36.13 x | 25.47 x |
|
Day 3
20-06-25 06:00 PM
|
(137.87 / 481.45) x | 117.68 x | 201.43 x |
Influx Healthtech Valuations
Earnings
- EPS Pre IPO
- ₹7.36/-
- EPS Post IPO
- ₹5.77/-
- P/E Pre IPO
- 13.04
- P/E Post IPO
- 16.63
Returns
- ROE
- 36.98%
- ROCE
- 49.17%
- RoNW
- 36.98%
- PAT Margin
- 12.75
Fundamentals
- Debt / Equity
- 0.01
- Price / Book
- 7.62
Influx Healthtech Financials( In Crs.)
| 31-Mar-25 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Assets | 70.30 | N/A | N/A |
| Revenue | 104.99 | N/A | N/A |
| Profit After Tax | 13.37 | N/A | N/A |
| Net Worth | 36.15 | N/A | N/A |
| Reserves & Surplus | 18.00 | N/A | N/A |
| Total Borrowing | 0.22 | N/A | N/A |
Influx Healthtech Company & Offer Insights
About Influx Healthtech
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-centric company dealing in contract manufacturing. The company is a trusted CDMO offering specialized services to clients in various industries. The company has three manufacturing plants in Thane, Maharashtra, each with an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively.
Product Portfolio:
Tablets, Capsules, and Powders
Liquid Orals and Softgels
Lozenges, Jellies, and Gummies
Oral Dispersible Films (ODFs)
Effervescent Tablets and Liquid-Fill Capsules
Candies and Gym/Sports Supplements
Skin Care and Body Care Products
Hair Care and Beard Care Solutions
Face Masks and Soaps.
Ayurvedic / Herbal formulations
Veterinary Feed Supplements
Homecare solutions
The Company assists Nutraceutical and Cosmetic companies with product development and manufacturing. It provides end-to-end solutions, from development to production and regulatory affairs, allowing customers to concentrate on formulation and commercialization.
As of June 11, 2025, there are 163 permanent employees on the payroll of the company.
Influx Healthtech Promoter(s)
Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala, Mr. Abdul Ganee Abdul Rasul Chandniwala. are the company's promoters of Influx Healthtech.
Influx Healthtech IPO Issue Objectives
- •
- Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division
- •
- Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division
- •
- Purchase of Machineries for Homecare and Cosmetic Division
- •
- General corporate purposes
Contact Information
Contact Details
Influx Healthtech
91 7045997809
109, Ghanshyam Enclave Premises Co-op, Soc Plot No. 856, Laljipada, Kandivali West, Mumbai, Maharashtra 400067
Registrar Contact Details
Maashitla Securities Private Limited
+91-11-45121795-96
Frequently Asked Questions
Click any question to reveal the answer
Influx Healthtech IPO is a book-built IPO worth ₹58.56 crore. The price band is ₹91–₹96 per share. The IPO opens on Jun 18, 2025 and closes on Jun 20, 2025. It will be listed on NSE SME Platform. Maashitla Securities Private Limited is the registrar.
The price band of Influx Healthtech IPO is ₹91 to ₹96 per share.
The lot size of Influx Healthtech IPO is 1200 shares.
The minimum investment for Influx Healthtech IPO is approximately ₹1,15,200 based on the upper price band .
Influx Healthtech IPO opens on Jun 18, 2025 and closes on Jun 20, 2025.
The allotment date of Influx Healthtech IPO is Jun 23, 2025.
Influx Healthtech IPO is expected to be listed on Jun 25, 2025, on NSE SME Platform.
Influx Healthtech IPO valuation snapshot: P/E 16.63, EPS ₹5.77/-, P/B 7.62, RoNW 36.98%, and market cap N/A.
To apply for Influx Healthtech IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Influx Healthtech IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Influx Healthtech IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Influx Healthtech IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Influx Healthtech IPO allotment status on IPO Ji for quick and easy access.